Edition:
United Kingdom

Galmed Pharmaceuticals Ltd (GLMD.OQ)

GLMD.OQ on NASDAQ Stock Exchange Capital Market

12.80USD
21 Sep 2018
Change (% chg)

$-0.03 (-0.23%)
Prev Close
$12.83
Open
$12.86
Day's High
$12.94
Day's Low
$12.60
Volume
16,268
Avg. Vol
139,525
52-wk High
$27.06
52-wk Low
$3.61

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.14 December 25 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 0
(2) OUTPERFORM 7 7 6 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.88 1.88 1.86 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 7 0.16 0.30 0.00 0.25
Quarter Ending Dec-18 7 0.16 0.30 0.00 0.25
Year Ending Dec-18 8 0.82 1.14 0.54 0.85
Year Ending Dec-19 7 0.53 2.00 0.00 0.67
Earnings (per share)
Quarter Ending Sep-18 8 -0.14 -0.09 -0.17 -0.21
Quarter Ending Dec-18 8 -0.15 -0.07 -0.20 -0.25
Year Ending Dec-18 8 -0.61 -0.48 -0.72 -1.18
Year Ending Dec-19 7 -1.06 -0.73 -1.70 -1.41

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.27 0.27 0.00 0.48
Quarter Ending Mar-18 0.30 0.27 0.03 10.67
Quarter Ending Dec-17 0.29 0.27 0.02 5.19
Quarter Ending Sep-17 0.32 0.27 0.05 14.37
Quarter Ending Jun-17 0.36 0.27 0.09 24.64

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.16 0.16 0.16 0.19 0.25
Quarter Ending Dec-18 0.16 0.16 0.16 0.19 0.25
Year Ending Dec-18 0.82 0.82 0.82 0.86 0.85
Year Ending Dec-19 0.53 0.53 0.53 1.02 0.67

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings